Alibaba Health Information Technology Limited (HKG:0241)
3.740
+0.110 (3.03%)
Jun 1, 2026, 4:08 PM HKT
HKG:0241 Cash Flow Statement
Financials in millions CNY. Fiscal year is April - March.
Millions CNY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,936 | 1,432 | 883.48 | 535.65 | -265.56 |
Depreciation & Amortization | 53.24 | 57.61 | 53.68 | 63.72 | 60.58 |
Loss (Gain) From Sale of Assets | - | -0.62 | -0.53 | 1.24 | -0.14 |
Loss (Gain) From Sale of Investments | 283.41 | 399.45 | 283.44 | -112.24 | -542.1 |
Loss (Gain) on Equity Investments | - | 64.66 | 5.93 | -11.38 | 45.62 |
Stock-Based Compensation | 162.12 | 224.54 | 266.06 | 308.89 | 408.1 |
Provision & Write-off of Bad Debts | - | 6.21 | 5.14 | 1.82 | 0.13 |
Other Operating Activities | -335.64 | -221.26 | -77.36 | 36.11 | 63.63 |
Change in Accounts Receivable | -214.34 | -273.59 | -211.49 | -64.63 | -201.98 |
Change in Inventory | -564.27 | -107.88 | 614.1 | -711.69 | -129.2 |
Change in Accounts Payable | 177.39 | -498.19 | -363.48 | 186.71 | 959.57 |
Change in Unearned Revenue | 157.39 | 140.41 | 59.62 | 234.39 | 70.1 |
Change in Other Net Operating Assets | -418.83 | 171.28 | -436.26 | -212.91 | -44.39 |
Operating Cash Flow | 1,237 | 1,395 | 1,080 | 255.69 | 424.36 |
Operating Cash Flow Growth | -11.36% | 29.19% | 322.32% | -39.75% | -57.96% |
Capital Expenditures | - | -18.89 | -22.77 | -5.61 | -14.93 |
Sale of Property, Plant & Equipment | - | 5.97 | 0.75 | 0.41 | 1.86 |
Cash Acquisitions | - | - | -131.03 | -77.33 | -815.6 |
Sale (Purchase) of Intangibles | - | -0.01 | -0.01 | -0.31 | -0.19 |
Investment in Securities | 1,628 | -2,943 | -4,857 | -512.48 | 2,799 |
Other Investing Activities | 393.01 | 348.79 | 115.89 | 47.08 | -112.09 |
Investing Cash Flow | 2,021 | -2,596 | -4,881 | -532.44 | 1,872 |
Long-Term Debt Repaid | -24.98 | -38.09 | -39.93 | -42.59 | -47.01 |
Total Debt Repaid | -24.98 | -38.09 | -39.93 | -42.59 | -47.01 |
Net Debt Issued (Repaid) | -24.98 | -38.09 | -39.93 | -42.59 | -47.01 |
Issuance of Common Stock | - | 4.59 | 0.88 | 12.89 | 9.69 |
Repurchase of Common Stock | - | -39.93 | -104.57 | -81.58 | -16.52 |
Other Financing Activities | 10.76 | 0.92 | -1,839 | - | -4.79 |
Financing Cash Flow | -14.22 | -72.52 | -1,982 | -111.28 | -58.63 |
Foreign Exchange Rate Adjustments | -27.64 | 2.09 | 36.78 | 283.45 | -148.89 |
Net Cash Flow | 3,216 | -1,272 | -5,747 | -104.58 | 2,089 |
Free Cash Flow | 1,237 | 1,376 | 1,057 | 250.08 | 409.43 |
Free Cash Flow Growth | -10.14% | 30.19% | 322.69% | -38.92% | -58.74% |
Free Cash Flow Margin | 3.61% | 4.50% | 3.91% | 0.93% | 1.99% |
Free Cash Flow Per Share | 0.08 | 0.09 | 0.07 | 0.02 | 0.03 |
Cash Interest Paid | - | 2.61 | 5.97 | 5.83 | 3.82 |
Cash Income Tax Paid | 332.12 | 106.93 | 40.61 | 43.11 | 45.34 |
Levered Free Cash Flow | 349.51 | 693.23 | 318.76 | -19.58 | 700.89 |
Unlevered Free Cash Flow | 350.38 | 694.86 | 322.49 | -15.93 | 703.27 |
Change in Working Capital | -862.66 | -567.97 | -337.52 | -568.13 | 654.1 |